Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247–56

Term Outcome ◽

Long Term Outcome ◽

Reply to Mustafa Aldemir and Abdullah Erdem Canda’s Letter to the Editor re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247–56

European Urology ◽

10.1016/j.eururo.2010.05.033 ◽

2010 ◽

Vol 58 (2) ◽

pp. e24-e25

Author(s):

Per-Uno Malmström ◽

Richard Sylvester

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

Reply to Donald Lamm, Andreas Böhle, Joan Palou, et al.’s Letter to the Editor re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247–56

European Urology ◽

10.1016/j.eururo.2009.10.034 ◽

2010 ◽

Vol 57 (2) ◽

pp. e10-e11

Author(s):

Per-Uno Malmström ◽

Richard J. Sylvester

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247–56

European Urology ◽

10.1016/j.eururo.2010.05.032 ◽

2010 ◽

Vol 58 (2) ◽

pp. e23

Author(s):

Mustafa Aldemir ◽

Abdullah Erdem Canda ◽

Mevlana Derya Balbay

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

European Urology ◽

10.1016/j.eururo.2009.04.038 ◽

2009 ◽

Vol 56 (2) ◽

pp. 247-256 ◽

Cited By ~ 357

Author(s):

Per-Uno Malmström ◽

Richard J. Sylvester ◽

David E. Crawford ◽

Martin Friedrich ◽

Susanne Krege ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

International braz j urol ◽

10.1590/s1677-55382009000600025 ◽

2009 ◽

Vol 35 (6) ◽

pp. 747-748

Author(s):

Andreas Bohle

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

651 IMMUNOTHERAPY OR CHEMOTHERAPY AS LOCAL THERAPY OF URINARY BLADDER CANCER – WHICH IS THE MOST EFFECTIVE? REPORT ON A META-ANALYSIS OF THE LONG-TERM OUTCOME OF RANDOMIZED STUDIES COMPARING INTRAVESICAL MITOMYCIN C VERSUS BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE BLADDER CANCER

European Urology Supplements ◽

10.1016/s1569-9056(09)60646-1 ◽

2009 ◽

Vol 8 (4) ◽

pp. 283 ◽

Cited By ~ 1

Author(s):

P.U. Malmström ◽

R. Sylvester ◽

E.D. Crawford ◽

M. Friedrich ◽

S. Krege ◽

...

Keyword(s):

Bladder Cancer ◽

Meta Analysis ◽

Local Therapy ◽

Urinary Bladder Cancer ◽

Term Outcome ◽

Long Term Outcome ◽

POD-7.08: Intravesical Mitomycin C Versus Bacillus Calmette-Guérin for Non-muscle Invasive Bladder Cancer: An Individual Patient Data Meta-analysis of Randomized Studies

Urology ◽

10.1016/j.urology.2008.08.161 ◽

2008 ◽

Vol 72 (5) ◽

pp. S57

Author(s):

P. Malmström ◽

R. Sylvester

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Patient Data ◽

Invasive Bladder Cancer ◽

Randomized Studies ◽

965 The long term outcome of high risk non-muscle invasive bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(12)60962-2 ◽

2012 ◽

Vol 11 (1) ◽

pp. e965-e965a

Author(s):

F. Thomas ◽

N. Rubin ◽

J. Goepel ◽

M.F. Abbod ◽

D. Rosario ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Term Outcome ◽

Long Term Outcome ◽

Re: Long-Term Outcome of Patients with Frequently Recurrent Non-Muscle-Invasive Bladder Carcinoma Treated with One Perioperative plus Four Weekly Instillations of Mitomycin C followed by Monthly bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study

The Journal of Urology ◽

10.1016/j.juro.2016.12.044 ◽

2017 ◽

Vol 197 (3 Part 1) ◽

pp. 605-606

Author(s):

Sam S. Chang

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Term Outcome ◽

Long Term Outcome ◽

Muscle Invasive ◽

Interferon Α2b

592 LONG TERM PROPHYLAXIS WITH MITOMYCIN C (MMC) SIGNIFICANTLY REDUCES TUMOR RECURRENCE COMPARED TO SHORT TERM PROPHYLAXIS WITH MMC OR BACILLUS CALMETTE-GUERIN (BCG) IN NON MUSCLE-INVASIVE BLADDER CANCER (NMIBC)

European Urology Supplements ◽

10.1016/s1569-9056(07)60590-9 ◽

2007 ◽

Vol 6 (2) ◽

pp. 170

Author(s):

M. Friedrich ◽

U. Pichlmeier ◽

H. Schwaibold ◽

S. Conrad ◽

H. Huland

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Tumor Recurrence ◽

Invasive Bladder Cancer ◽

Short Term ◽

Muscle Invasive ◽

Short Term Prophylaxis